“The present predicament has uncovered some structural weaknesses within the EU’s medicines provide chain along with a substantial dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides stated. She suggested that provide chain problems be addressed in an EU pharmaceutical tactic envisioned to become introduced by the end in the https://www.rilife.co/blog/